Yusuke Yokota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yusuke Yokota has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Susumu Tanaka
Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, The University of Osaka, Suita, Japan
8 shared publications - Emiko Tanaka Isomura
Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, The University of Osaka, Suita, Japan
7 shared publications - Soju Seki
Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, The University of Osaka, Suita, Japan
6 shared publications Emiko Tanaka Isomura
Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry Osaka University Suita Japan
3 shared publicationsK. Nohara
Osaka Univ Dent Hosp, Ctr Cleft Lip & Palate Treatment, Suita, Osaka, Japan
3 shared publicationsM. Kogo
First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, 1-8 Yamadaoka, Suita, Osaka, Japan
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in Oral Oncology Reports
- Vol. 20
Risk factors and treatment outcomes of metachronous isolated distant metastasis in oral squamous cell carcinoma: A multicenter retrospective cohort study in Japan
- 21 October 2026
- Published by Elsevier in Oral Oncology Reports
- Vol. 20
Open AccessRisk factors and treatment outcomes of metachronous isolated distant metastasis in oral squamous cell carcinoma: A multicenter retrospective cohort study in Japan
- Open Access
A bone fragment-based protocol for molecular analysis of osteocyte-associated transcripts in human bone specimens
Osteocytes play a central role in bone remodeling, mineral metabolism, and skeletal homeostasis, but direct molecular analysis of human osteocytes remains technically challenging because they are embedded within the mineralized bone matrix. Surgically obtained human bone specimens provide valuable material for studying human bone biology; however, surface-associated cells, marrow-derived cells, and adherent soft tissues can confound downstream transcript analysis. Here, we describe a bone fragment-based protocol for preparing surgically obtained human bone specimens for molecular analysis of osteocyte-associated transcripts. The protocol consists of mechanical trimming, mincing into small bone fragments, repeated washing, and five sequential rounds of collagenase digestion to reduce non-osteocytic cellular components associated with the bone surface and marrow spaces. The remaining mineralized bone fragments are then frozen in liquid nitrogen, cryogenically pulverized, and lysed in TRIzol™ reagent for total RNA extraction. Histological validation using residual maxillary bone specimens showed that sequential collagenase digestion markedly reduced adherent soft tissue and extra-matrix nuclei while preserving osteocyte lacunar occupancy. This protocol provides a practical workflow for bone fragment-based RNA analysis focused on osteocyte-associated transcripts in human bone specimens. Specifications table:
Open AccessA bone fragment-based protocol for molecular analysis of osteocyte-associated transcripts in human bone specimens
Osteocytes play a central role in bone remodeling, mineral metabolism, and skeletal homeostasis, but direct molecular analysis of human osteocytes remains technically challenging because they are embedded within the mineralized bone matrix. Surgically obtained human bone specimens provide valuable material for studying human bone biology; however, surface-associated cells, marrow-derived cells, and adherent soft tissues can confound downstream transcript analysis. Here, we describe a bone fragment-based protocol for preparing surgically obtained human bone specimens for molecular analysis of osteocyte-associated transcripts. The protocol consists of mechanical trimming, mincing into small bone fragments, repeated washing, and five sequential rounds of collagenase digestion to reduce non-osteocytic cellular components associated with the bone surface and marrow spaces. The remaining mineralized bone fragments are then frozen in liquid nitrogen, cryogenically pulverized, and lysed in TRIzol™ reagent for total RNA extraction. Histological validation using residual maxillary bone specimens showed that sequential collagenase digestion markedly reduced adherent soft tissue and extra-matrix nuclei while preserving osteocyte lacunar occupancy. This protocol provides a practical workflow for bone fragment-based RNA analysis focused on osteocyte-associated transcripts in human bone specimens. Specifications table:
- Open Access
- 13 November 2025
- Published by Elsevier in Oral Oncology
- Vol. 171, 107771
T4a classification for oral cancer using mandibular canal invasion instead of bone marrow invasion in the TNM staging system
- 13 November 2025
- Published by Elsevier in Oral Oncology
- Vol. 171, 107771
Open AccessT4a classification for oral cancer using mandibular canal invasion instead of bone marrow invasion in the TNM staging system
- Open Access
- 2 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4346
Role and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis
Neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), present significant challenges owing to their complex pathologies and a lack of curative treatments. Early detection and reliable biomarkers are critical but remain elusive. Artificial intelligence (AI) has emerged as a transformative tool, enabling advancements in biomarker discovery, diagnostic accuracy, and therapeutic development. From optimizing clinical-trial designs to leveraging omics and neuroimaging data, AI facilitates understanding of disease and treatment innovation. Notably, technologies such as AlphaFold and deep learning models have revolutionized proteomics and neuroimaging, offering unprecedented insights into ALS pathophysiology. This review highlights the intersection of AI and ALS, exploring the current state of progress and future therapeutic prospects.
- 2 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4346
Open AccessRole and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis
Neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), present significant challenges owing to their complex pathologies and a lack of curative treatments. Early detection and reliable biomarkers are critical but remain elusive. Artificial intelligence (AI) has emerged as a transformative tool, enabling advancements in biomarker discovery, diagnostic accuracy, and therapeutic development. From optimizing clinical-trial designs to leveraging omics and neuroimaging data, AI facilitates understanding of disease and treatment innovation. Notably, technologies such as AlphaFold and deep learning models have revolutionized proteomics and neuroimaging, offering unprecedented insights into ALS pathophysiology. This review highlights the intersection of AI and ALS, exploring the current state of progress and future therapeutic prospects.
- 6 February 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (1) , 100627
Zinc deficiency enhances salt preference through altered peripheral and central taste processing mechanisms
- 6 February 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (1) , 100627
Zinc deficiency enhances salt preference through altered peripheral and central taste processing mechanisms
- 9 May 2024
- Published by Wiley in Oral Science International
- Vol. 22 (1)
A case of a giant Bailey type I lateral cervical cyst
Background: Lateral cervical cysts are among the most frequent branchial anomalies of the neck, although they rarely become large.Case presentation: The present case involved a 32‐year‐old man with swelling of the right side of the neck. Pre‐operative CT findings showed a low CT value on the right side of the neck. Lateral cervical cyst removal was performed under general anesthesia, and the excision was 100 mm × 70 mm × 30 mm, which is the largest ever reported removal of a Bailey type I lateral cervical cyst.Conclusion: The patient had a good clinical course, with no post‐operative recurrence.
- 9 May 2024
- Published by Wiley in Oral Science International
- Vol. 22 (1)
A case of a giant Bailey type I lateral cervical cyst
Background: Lateral cervical cysts are among the most frequent branchial anomalies of the neck, although they rarely become large.Case presentation: The present case involved a 32‐year‐old man with swelling of the right side of the neck. Pre‐operative CT findings showed a low CT value on the right side of the neck. Lateral cervical cyst removal was performed under general anesthesia, and the excision was 100 mm × 70 mm × 30 mm, which is the largest ever reported removal of a Bailey type I lateral cervical cyst.Conclusion: The patient had a good clinical course, with no post‐operative recurrence.
- Open Access
- 27 April 2024
- Published by Elsevier in Brain Research
- Vol. 1837, 148955
Swallowing-like activity elicited in neonatal rat medullary slice preparation
- 27 April 2024
- Published by Elsevier in Brain Research
- Vol. 1837, 148955
Open AccessSwallowing-like activity elicited in neonatal rat medullary slice preparation
- Open Access
- 3 November 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (11) , 2967
Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterised by the progressive degeneration of motor neurons, resulting in muscle weakness, paralysis, and, ultimately, death. Presently, no effective treatment for ALS has been established. Although motor neuron dysfunction is a hallmark of ALS, emerging evidence suggests that sensory neurons are also involved in the disease. In clinical research, 30% of patients with ALS had sensory symptoms and abnormal sensory nerve conduction studies in the lower extremities. Peroneal nerve biopsies show histological abnormalities in 90% of the patients. Preclinical research has reported several genetic abnormalities in the sensory neurons of animal models of ALS, as well as in motor neurons. Furthermore, the aggregation of misfolded proteins like TAR DNA-binding protein 43 has been reported in sensory neurons. This review aims to provide a comprehensive description of ALS-related sensory neuron dysfunction, focusing on its clinical changes and underlying mechanisms. Sensory neuron abnormalities in ALS are not limited to somatosensory issues; proprioceptive sensory neurons, such as MesV and DRG neurons, have been reported to form networks with motor neurons and may be involved in motor control. Despite receiving limited attention, sensory neuron abnormalities in ALS hold potential for new therapies targeting proprioceptive sensory neurons.
- 3 November 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (11) , 2967
Open AccessCharacteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterised by the progressive degeneration of motor neurons, resulting in muscle weakness, paralysis, and, ultimately, death. Presently, no effective treatment for ALS has been established. Although motor neuron dysfunction is a hallmark of ALS, emerging evidence suggests that sensory neurons are also involved in the disease. In clinical research, 30% of patients with ALS had sensory symptoms and abnormal sensory nerve conduction studies in the lower extremities. Peroneal nerve biopsies show histological abnormalities in 90% of the patients. Preclinical research has reported several genetic abnormalities in the sensory neurons of animal models of ALS, as well as in motor neurons. Furthermore, the aggregation of misfolded proteins like TAR DNA-binding protein 43 has been reported in sensory neurons. This review aims to provide a comprehensive description of ALS-related sensory neuron dysfunction, focusing on its clinical changes and underlying mechanisms. Sensory neuron abnormalities in ALS are not limited to somatosensory issues; proprioceptive sensory neurons, such as MesV and DRG neurons, have been reported to form networks with motor neurons and may be involved in motor control. Despite receiving limited attention, sensory neuron abnormalities in ALS hold potential for new therapies targeting proprioceptive sensory neurons.
- 30 October 2023
- Published by Wiley in Oral Science International
- Vol. 21 (3) , 317-325
3D morphological changes of the lip and face in patients with cleft lip and alveolus: The comparison of the lip development of incomplete and complete cleft lips under 3 months of age
To treat cleft lip and palate, it is critical to understand the development of the lips and face. Objective: The objective of this study is to comprehend the development of lips and facial features in patients with cleft lip from birth to cheiloplasty. A comparison of incomplete and complete cleft lips was performed. Methods: The morphology of the lips and face was recorded using a noncontact three‐dimensional morphology recorder from shortly after birth to cheiloplasty. For each patient, their soft tissue growth was analyzed. Results: These findings suggest that an incomplete cleft widens the gap between healthy and affected sides from 2 to 3 months of age. The pattern is different from that of a complete cleft.
- 30 October 2023
- Published by Wiley in Oral Science International
- Vol. 21 (3) , 317-325
3D morphological changes of the lip and face in patients with cleft lip and alveolus: The comparison of the lip development of incomplete and complete cleft lips under 3 months of age
To treat cleft lip and palate, it is critical to understand the development of the lips and face. Objective: The objective of this study is to comprehend the development of lips and facial features in patients with cleft lip from birth to cheiloplasty. A comparison of incomplete and complete cleft lips was performed. Methods: The morphology of the lips and face was recorded using a noncontact three‐dimensional morphology recorder from shortly after birth to cheiloplasty. For each patient, their soft tissue growth was analyzed. Results: These findings suggest that an incomplete cleft widens the gap between healthy and affected sides from 2 to 3 months of age. The pattern is different from that of a complete cleft.